Today, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is meeting to discuss the first request for emergency use authorization for a vaccine for COVID-19 prevention, submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3gAqPaN
No comments:
Post a Comment